Institution profile

社会医療法人愛仁会 高槻病院

Explore the institution's name, address and registered technologies as published, along with plan classifications, score components and sources.

The ranking reflects only the registration data published by Japan's Ministry of Health, Labour and Welfare; it does not represent treatment outcomes or quality of care. Scoring method →

Source: Ministry of Health, Labour and Welfare public directory of regenerative medicine providers MHLW e-Regenerative Medicine public register · Directory archive date I: 2026-07-19 / II: 2026-09-26 / III: 2026-05-18 · Internet Archive

MHLW e-Regenerative Medicine public registerPublic document number 03E2504006 +2

Location

Prefecture
Osaka
Address
高槻市古曽部町1丁目3番13号

Plan classification

  • Class INot registered
  • Class IIThe medium-risk category under the law.
  • Class IIINot registered

Certified committee for regenerative medicine

  • 先端医療推進機構特定認定再生医療等委員会名古屋
  • 安全未来特定認定再生医療等委員会

Public score

53.9/ 100

A · Review level
25.0 / 30
B · Technologies
15.9 / 35
C · Coverage
7.1 / 25
D · Class I / II technologies
5.8 / 10

The public score is calculated from public registration information and does not reflect quality of care. Scoring method →

Overall ranking

No. 354of 1736

Registered technologies
3
Areas covered
2

Technology areas · Rank

Position in the overall score distribution

0–100 · Public score
000–9.9 · 0 institutions
01010–19.9 · 0 institutions
2172020–29.9 · 217 institutions
3163030–39.9 · 316 institutions
7564040–49.9 · 756 institutions
2465050–59.9 · 246 institutions
1326060–69.9 · 132 institutions
417070–79.9 · 41 institutions
248080–89.9 · 24 institutions
49090–100 · 4 institutions
This institution 53.9
Public score →100

Registered technologies (3)

Stem cells (all sources) 3
Registered technologies · Japanese originalTechnology areasPlan classification
自家脂肪組織由来の培養間葉系幹細胞を用いた変形性膝関節症の治療Stem cells (all sources)Adipose-derived stem cellsJoints and musculoskeletalClass II
脊髄損傷(SCI)に対する脂肪組織由来再生幹細胞を用いた細胞医療Stem cells (all sources)Adipose-derived stem cellsClass II
変形性関節症(膝、股関節、足関節等)、四肢スポーツ障害(筋腱靭帯半月板障害)、偽関節・遷延治癒骨折などの整形外科疾患に対する、脂肪組織由来再生(幹)細胞(Adipose Derived Regenerative Cells: ADRCs)による治療Stem cells (all sources)Adipose-derived stem cellsJoints and musculoskeletalClass II
Adipose-derived stem cells 3
Registered technologies · Japanese originalTechnology areasPlan classification
自家脂肪組織由来の培養間葉系幹細胞を用いた変形性膝関節症の治療Stem cells (all sources)Adipose-derived stem cellsJoints and musculoskeletalClass II
脊髄損傷(SCI)に対する脂肪組織由来再生幹細胞を用いた細胞医療Stem cells (all sources)Adipose-derived stem cellsClass II
変形性関節症(膝、股関節、足関節等)、四肢スポーツ障害(筋腱靭帯半月板障害)、偽関節・遷延治癒骨折などの整形外科疾患に対する、脂肪組織由来再生(幹)細胞(Adipose Derived Regenerative Cells: ADRCs)による治療Stem cells (all sources)Adipose-derived stem cellsJoints and musculoskeletalClass II
Joints and musculoskeletal 2
Registered technologies · Japanese originalTechnology areasPlan classification
自家脂肪組織由来の培養間葉系幹細胞を用いた変形性膝関節症の治療Stem cells (all sources)Adipose-derived stem cellsJoints and musculoskeletalClass II
変形性関節症(膝、股関節、足関節等)、四肢スポーツ障害(筋腱靭帯半月板障害)、偽関節・遷延治癒骨折などの整形外科疾患に対する、脂肪組織由来再生(幹)細胞(Adipose Derived Regenerative Cells: ADRCs)による治療Stem cells (all sources)Adipose-derived stem cellsJoints and musculoskeletalClass II

Certified committee for regenerative medicine

  • 先端医療推進機構特定認定再生医療等委員会名古屋
  • 安全未来特定認定再生医療等委員会

Public document number

  • 03E2504006
  • 02E2509004
  • 02E2509002
Plan classification · Certified committee for regenerative medicine · Public document number
Registered technologiesPlan classificationCertified committee for regenerative medicinePublic document number
自家脂肪組織由来の培養間葉系幹細胞を用いた変形性膝関節症の治療Class II先端医療推進機構特定認定再生医療等委員会名古屋03E2504006
脊髄損傷(SCI)に対する脂肪組織由来再生幹細胞を用いた細胞医療Class II安全未来特定認定再生医療等委員会02E2509004
変形性関節症(膝、股関節、足関節等)、四肢スポーツ障害(筋腱靭帯半月板障害)、偽関節・遷延治癒骨折などの整形外科疾患に対する、脂肪組織由来再生(幹)細胞(Adipose Derived Regenerative Cells: ADRCs)による治療Class II安全未来特定認定再生医療等委員会02E2509002

Other institutions in the same prefecture

← Institution directory
One-to-one advice

Still unsure? Ask an advisor

Use the “Chat with an advisor” button on this page (at the bottom of the screen on mobile, bottom right on desktop) to open a chat with the Stem Cell Japan advice desk. Consultation and coordination are free, and an advisor replies within one working day.

Chat with an advisor